Vaccines, blood, antisera, toxins and cultures in Brazil | The Observatory of Economic Complexity

About

Exports In 2023, Brazil exported $183M in Vaccines, blood, antisera, toxins and cultures, making it the 35th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 162nd most exported product in Brazil. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Brazil are: United Kingdom ($25.2M), Colombia ($16.3M), Uruguay ($14M), Sweden ($11.3M), and Paraguay ($9.27M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Brazil between 2022 and 2023 were Colombia ($10.1M), Sweden ($9.28M), and Estonia ($3.39M).

Imports In 2023, Brazil imported $5.48B in Vaccines, blood, antisera, toxins and cultures, becoming the 15th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most imported product in Brazil. Brazil imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($1.15B), Germany ($866M), United States ($834M), Switzerland ($743M), and Ireland ($557M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Brazil between 2022 and 2023 were Germany ($279M), Ireland ($174M), and Austria ($69M).

Latest Trends

January 2025

About

Overview In January 2025 Brazil's Vaccines, blood, antisera, toxins and cultures exports accounted up to $8.28M and imports accounted up to $478M, resulting in a negative trade balance of $470M. Between January 2024 and January 2025 the exports of Brazil's Vaccines, blood, antisera, toxins and cultures have increased by $1.97M (31.2%) from $6.31M to $8.28M, while imports decreased by $-39.1M (-7.57%) from $517M to $478M.

Destinations In January 2025, Vaccines, blood, antisera, toxins and cultures were exported mostly to Paraguay ($1.5M), Russia ($1.36M), China ($882k), Colombia ($690k), and United Kingdom ($631k), and were imported mostly from Germany ($122M), United States ($71M), Switzerland ($65.5M), South Korea ($34M), and Ireland ($26.9M).

Growth In January 2025, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Paraguay ($952k or 301%), Venezuela ($351k or 219%), and Chile ($209k or 645%). In January 2025, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Belgium ($-321M or -94.1%), Denmark ($-22.6M or -91.9%), and Japan ($-11.4M or -69.7%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (January 2024 - January 2025)$1.97M(31.2%)

IMPORT GROWTH (January 2024 - January 2025)$-39.1M(-7.57%)

MAIN EXPORTER (January 2025)São Paulo$2.61M

MAIN DESTINATION (January 2025)Paraguay$1.5M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Brazil. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download